Abstract
Idiopathic pulmonary fibrosis (IPF) is a fibroproliferative lung disorder of unknown aetiology. Transforming growth factor-β1 (TGF-β1)-mediated Smad and non-Smad signaling cascades are considered as central players in accelerating pulmonary fibrosis. We earlier reported berberine’s amelioration against TGF-β1-mediated pro-fibrotic effects in bleomycin-induced pulmonary fibrosis. The present study aimed to determine the regulatory role of berberine on abrogated Smad 2/3 and FAK-dependent PI3K/Akt-mTOR signaling cascades in bleomycin-induced pulmonary fibrosis. Male Wistar rats were subjected to single intratracheal instillation of bleomycin (2.5 U/kg) on day 0, and berberine treatments were provided in either preventive or therapeutic modes, respectively. Berberine mitigated the elevated expression of fibrotic markers, α-smooth muscle actin (α-SMA), fibronectin, collagens I and III and reversed bleomycin-induced ultrastructural alterations in the lungs. Berberine inhibited the bleomycin-induced raise in p-Smad 2/3 and enhanced Smad 7 expression. Berberine blocked the activation of FAK and PI3K/Akt against bleomycin-induced dysregulation, with subsequent raise in PTEN expression. In addition, by inhibiting p-mTOR, berberine stimulated autophagy as evidenced by increase in Beclin-1, LC3-II levels with enhanced autophagosome formation. Cumulatively, through targeted inhibition of dysregulated Smad and FAK-dependent PI3K/Akt-mTOR signaling axis, berberine attenuated the fibrotic insults of bleomycin.
Key message
-
Berberine inhibits Smad 2/3 activation and enhances Smad 7 in bleomycin-induced rat lungs.
-
Bleomycin-induced activation of FAK is inhibited by berberine.
-
Berberine inhibits bleomycin-induced activation of PI3K/Akt cascade.
-
Berberine inhibits mTOR activation to enhance autophagy and suppresses fibrotic markers.
Similar content being viewed by others
References
Schwartz DA, Helmers RA, Galvin JR, Fossen DS, Frees KL, Dayton CS, Burmeister LF, Hunninghake GW (1994) Determinants of survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 149:450
Selman M, King TE, Pardo A (2001) Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med 134:136
Hu Q, Noor M, Wong YF, Peter JH, Simmonds MSJ, Xu Q, Jiang D, Hendry BM, Xu Q (2009) In vitro anti-fibrotic activities of herbal compounds and herbs. Nephrol Dial Transplant 24:3033–3041
Chitra P, Saiprasad G, Manikandan R, Sudhandiran G (2013) Berberine attenuates bleomycin induced pulmonary toxicity and fibrosis via suppressing NF-κB dependant TGF-β activation: a biphasic experimental study. Toxicol Lett 219:178
Thomas AW (2011) Integrating mechanisms of pulmonary fibrosis. JEM 208(7):1339–1350
Higashiyama H, Yoshimoto D, Okamoto Y, Kikkawa H, Asano S, Kinoshita M (2007) Receptor-activated Smad localization in bleomycin-induced pulmonary fibrosis. J Clin Pathol 60(3):283–289
Hong M, Wilkes MC, Penheiter SG, Gupta SK, Edens M, Leof EB (2011) Non-Smad transforming growth factor-β signaling regulated by focal adhesion kinase binding the p85 subunit of phosphatidylinositol 3-kinase. J Biol Chem 286(20):17841–17850
Tsodikova SG, Thannickal VJ (2008) Protein kinase inhibitors in the treatment of pulmonary fibrosis. Curr Med Chem 15(25):2632–2640
**a H, Khalil W, Kahm J, Jessurun J, Kleidon J, Craig AH (2010) Pathologic caveolin-1 regulation of PTEN in idiopathic pulmonary fibrosis. Am J Pathol 176(6):2626–2637
Haspel JA, Choi AM (2011) Autophagy: a core cellular process with emerging links to pulmonary disease. Am J Respir Crit Care Med 184:1237–1246
Jung CH, Ro SH, Cao J, Otto NM, Kim DH (2010) mTOR regulation of autophagy. FEBS Lett 584:1287
Korfhagen TR, Le Cras TD, Davidson CR, Schmidt SM, Ikegami M, Whitsett JA, Hardie WD (2009) Rapamycin prevents transforming growth factor-alpha-induced pulmonary fibrosis. Am J Respir Cell Mol Biol 41:562–572
Chaudhary NI, Schnapp A, Park JE (2006) Pharmacologic differentiation of inflammation and fibrosis in the rat bleomycin model. Am J Respir Crit Care Med 173:769–776
Rickwood D, Messent A, Patel D (2006) Isolation and functional analysis of organelles. Cell biology protocols. Oxford University Press, New York, p 71
Leask A, Abraham DJ (2004) TGF-β signaling and the fibrotic response. FASEB J 18(7):816–827
Parameswara RV, Subhashis C, Sanjay S (2010) Berberine: a potential phytochemical with multispectrum therapeutic activities. Expert Opin Investig Drugs 19(10):1297–1307
Cutroneo KR, White SL, Phan SH, Ehrlich HP (2007) Therapies for bleomycin induced lung fibrosis through regulation of TGF-beta1 induced collagen gene expression. J Cell Physiol 211(3):585–589
Chen YL, Zhang X, Bai J, Gai L, Ye XL, Zhang L, Xu Q, Zhang YX, Xu L, Li HP et al (2013) Sorafenib ameliorates bleomycin-induced pulmonary fibrosis: potential roles in the inhibition of epithelial–mesenchymal transition and fibroblast activation. Cell Death Dis 4:e665
Willis BC, Borok Z (2007) TGF-beta-induced EMT: mechanisms and implications for fibrotic lung disease. Am J Physiol Lung Cell Mol Physiol 293:525–534
Venkatesan N, Pini L, Ludwig MS (2004) Changes in Smad expression and subcellular localization in bleomycin-induced pulmonary fibrosis. Am J Physiol 287(6):1342–1347
Wang FM, Yang YJ, Ma LL, Tian XJ, He YQ (2014) Berberine ameliorates renal interstitial fibrosis induced by unilateral ureteral obstruction in rats. Nephrology 19(9):542–551
Sieg DJ, Hauck CR, Ilic D, Klingbeil CK, Schaefer E, Damsky CH, Schlaepfer DD (2000) FAK integrates growth factor and integrin signals to promote cell migration. Nat Cell Biol 2(5):249–256
Kinoshita K, Aono Y, Azuma M, Kishi J, Takezaki A, Kishi M, Makino H, Okazaki H, Uehara H, Izumi K et al (2013) Antifibrotic effects of focal adhesion kinase inhibitor in bleomycin-induced pulmonary fibrosis in mice. Am J Respir Cell Mol Biol 49(4):536
Ho YT, Yang JS, Li TC, Lin JJ, Lin JG, Lai KC, Ma CY, Wood WG, Chung JG (2009) Berberine suppresses in vitro migration and invasion of human SCC-4 tongue squamous cancer cells through the inhibitions of FAK, IKK, NF-kappaB, u-PA and MMP-2 and -9. Cancer Lett 279(2):155–162
Chen HC, Appeddu PA, Isoda H, Guan JL (1999) Phosphorylation of tyrosine 397 in focal adhesion kinase is required for binding phosphatidylinositol 3-kinase. J Biol Chem 271:26329
Engelman JA, Luo J, Cantley LC (2006) The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat Rev Genet 7:606–619
Cantley LC (2002) The phosphoinositide 3-kinase pathway. Science 296(5573):1655–1657
Lu Y, Azad N, Wang L, Iyer AK, Castranova V, Jiang BH, Rojanasakul Y (2010) Phosphatidylinositol-3-kinase/Akt regulates bleomycin-induced fibroblast proliferation and collagen production. Am J Respir Cell Mol Biol 42:432–441
Miyoshi K, Yanagi S, Kawahara K, Nishio M, Tsubouchi H, Imazu Y, Koshida R, Matsumoto N, Taguchi A, Yamashita S et al (2013) Epithelial Pten controls acute lung injury and fibrosis by regulating alveolar epithelial cell integrity. Am J Respir Crit Care Med 187(3):262–275
Gvaramia D, Blaauboer ME, Hanemaaijer R, Everts V (2013) Role of caveolin-1 in fibrotic diseases. Matrix Biol 32(6):307–315
Liu B, Wang G, Yang J, Pan X, Yang Z, Zang L (2011) Berberine inhibits human hepatoma cell invasion without cytotoxicity in healthy hepatocytes. PLoS One 6(6):e21416
Araya J, Kojima J, Takasaka N, Ito S, Fujii S, Hara H, Yanagisawa H, Kobayashi K, Tsurushige C, Kawaishi M et al (2013) Insufficient autophagy in idiopathic pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 304(1):L56–L69
Patel AS, Ling L, Alexander G, Jeffrey AH, Chang HA, Jiaofei C, Rosas IO, Morse D (2012) Autophagy in idiopathic pulmonary fibrosis. PLoS One 7(7):e41394
Mi S, Li Z, Yang HZ, Liu H, Wang JP, Ma YG, Wang XX, Liu HZ, Sun W, Hu ZW (2011) Blocking IL-17A promotes the resolution of pulmonary inflammation and fibrosis via TGF-beta1-dependent and -independent mechanisms. J Immunol 187:3003–3014
Zhang YJ, Yang SH, Li MH, Iqbal J, Bourantas CV, Mi QY, Yu YH, Li JJ, Zhao SL, Tian NL et al (2014) Berberine attenuates adverse left ventricular remodeling and cardiac dysfunction after acute myocardial infarction in rats: role of autophagy. Clin Exp Pharmacol Physiol. doi:10.1111/1440-1681.12309
Acknowledgments
This work is in part supported by University Grant Commission (UGC-BSR/meritorious fellowship) New Delhi, India. The authors thank All India Institute of Medical Sciences (AIIMS) and Jawaharlal Nehru University (JNU), New Delhi, India, for their assistance and guidance in ultrastructural studies. The authors also thank Dr. Ramamurthy, director, Ultrafast Process Laboratory, University of Madras, for his assistance in confocal imaging.
Conflict of interest
The authors declared no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
ESM 1
(PDF 834 kb)
Rights and permissions
About this article
Cite this article
Chitra, P., Saiprasad, G., Manikandan, R. et al. Berberine inhibits Smad and non-Smad signaling cascades and enhances autophagy against pulmonary fibrosis. J Mol Med 93, 1015–1031 (2015). https://doi.org/10.1007/s00109-015-1283-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00109-015-1283-1